Transcript David Kretzmann: David Kretzmann here at the Benzinga Cannabis Capital Conference here in Toronto, and I’m joined by a special guest right now, the CFO of OrganiGram, Paolo De Luca. Paolo, thanks so much for taking some time to talk to The Fool. We had a chance to speak to your CEO, Greg Engel, a couple months ago, but before we dive into the latest with OrganiGram, you joined the company in December. I’m just curious if you could walk us through what drew you to OrganiGram? Paolo De Luca: Great. Thanks for having me. I joined the company in December of 2017. One of the things that really appealed to me about the company and the industry was obviously that Canada is on the leading edge of the recreational movement around the world. We’ll be the second company to be legal from a recreational perspective after Uruguay, and cannabis is also becoming, by way of its sophisticated capital markets and also the fact that the medical program has been around for a few years and we’re launching recreational in October, it’s becoming the center of capital formation, so you’re seeing a lot of even U.S. cannabis companies listing on our Canadian Securities Exchange [inaudible 00:01:15] so we have three exchanges, the TSX, the TSX Venture, and now the Canadian Securities Exchange that list cannabis stock, so there’s a lot of expertise that’s developing here.